BMRN vs CGTX · P/E 40, rev $1.76B vs $120.8M cap
Biomarin Pharmaceutical Inc (BMRN) versus Cognition Therapeutics Inc (CGTX) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Cognition Therapeutics Inc (CGTX) is a biotechnology company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
CGTX does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. CGTX currently screens at market cap $120.8M.
Not investment advice. Open the BMRN and CGTX stock pages for the full models.
Not investment advice.